{"schema_version":"secwatch.filing_event.v1","accession":"0001477449-24-000083","form_type":"8-K","ticker":"TDOC","cik":"0001477449","company_name":"Teladoc Health, Inc.","filed_at":"2024-04-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.587238+00:00","generated_at":"2026-06-04T01:45:51.795599+00:00","sec_items":["2.02","5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Teladoc CEO Jason Gorevic departs; CFO Mala Murthy named acting CEO","bullets":["Jason Gorevic departs immediately; Board retains search firm for permanent successor.","CFO Mala Murthy appointed acting CEO, retains CFO role; base salary raised to $750k, target bonus 120%, additional equity $1.1M.","Company reaffirms Q1 2024 and full-year 2024 guidance, consistent with Feb 20 earnings release.","Gorevic eligible for separation benefits per employment agreement subject to release."],"urls":{"canonical":"https://secwatch.observer/filing/0001477449-24-000083","json":"https://secwatch.observer/filing/0001477449-24-000083.json","markdown":"https://secwatch.observer/filing/0001477449-24-000083.md","text":"https://secwatch.observer/filing/0001477449-24-000083.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1477449/000147744924000083/0001477449-24-000083-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1477449/000147744924000083/tdoc-20240405.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T01:45:51.795599+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"631cd433e697068d6e9bfc28798d7e41e25a9874","claim":"Teladoc Health, Inc. updated its quarter ended March 31, 2024 guidance (reaffirmed).","evidence_excerpt":"On April 5, 2024, Teladoc Health, Inc. (“Teladoc Health” or the “Company”) announced that it continues to expect its outlook for the quarter ended March 31, 2024 and the year ending December 31, 2024 to be consistent with the outlook ranges disclosed in the Company’s earnings release on February 20, 2024. The financial results for the quarter ended March 31, 2024 are preliminary, unaudited and subject to change","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1477449/000147744924000083/0001477449-24-000083-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"quarter ended March 31, 2024"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"preliminary results"}],"fact_type":"earnings_release"},{"claim_id":"01ad94af10","claim":"Mala Murthy was appointed as acting Chief Executive Officer at Teladoc Health, Inc..","evidence_excerpt":"Teladoc Health announced the appointment of Mala Murthy to the position of acting Chief Executive Officer of the Company, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1477449/000147744924000083/0001477449-24-000083-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"acting Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"a2d46553ae","claim":"Jason Gorevic departed as Chief Executive Officer at Teladoc Health, Inc..","evidence_excerpt":"replacing Jason Gorevic, who will also depart from the Board of Directors of the Company as required by his employment agreement.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1477449/000147744924000083/0001477449-24-000083-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"departed"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}